EUVIMEDEUVIMED entdecken
Crossref

Assessing type I collagen expression and quality in cellular models of osteogenesis imperfecta

Prajna Udupa, Akshaykumar Nanaji Shrikondawar, Akash Ranjan, Debasish Kumar Ghosh iD

Clinical Genetics · 2024

DOI: 10.1111/cge.14463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2024. Verfasst von Prajna Udupa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India. Hauptthemen laut MEDLINE: Collagen Type I, Osteogenesis Imperfecta. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteogenesis imperfecta (OI) is a group of genetic disorders of bone formation characterized by soft and shorter brittle bones in affected individuals. OI is generally considered a collagenopathy resulting from abnormal expression of type I collagen. As assay system to detect the cellular level and quality of type I collagen would help in rapid and correct detection of OI from the diagnostic perspectives. Here, we report an immunofluorescence assay for detection of type I collagen in fibroblast models of OI and represented them into two broad categories based on the expression level and aggregation characteristics of pro‐α1(I). Cell phenotypic assays of pro‐α1(I) in OI‐related gene knocked down fibroblasts revealed aggregates of pro‐α1(I) in conditions with knockdown of SERPINF1 , CRTAP , P3H1 , PPIB , SERPINH1 , FKBP10 , TMEM38B , MESD , and KDELR2 , whereas pro‐α1(I) expression was very low in fibroblasts which had knockdown of IFITM5 , SP7 , BMP1 , WNT1 , CREB3L1 , MBTPS2 , and CCDC134 . The expression of pro‐α1(I) showed abundant and non‐aggregated distribution in the fibroblasts with knockdown of non‐OI skeletal disorder‐related genes ( RAB33B and IFT52 ). The in vitro assay accurately detected abnormally expressed pro‐α1(I) levels in cellular models of various types of OI. Thus, this procedure represents a promising point‐of‐detection assay for potential diagnosis and therapeutic decisions in OI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IOsteogenesis ImperfectaHumansGenes, RecessiveFibroblastsMutationVesicular Transport ProteinsMembrane Proteins

Stichwörter der Autor:innen

detection assayimmunofluorescenceosteogenesis imperfectaprotein aggregationtype I collagen

Substanzen

Collagen Type IKDELR2 protein, humanVesicular Transport ProteinsCCDC134 protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Computational and Functional Genomics Group, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India.

ORCID-Profile: Debasish Kumar Ghosh

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Udupa, P., Shrikondawar, A. N., Ranjan, A., & Ghosh, D. K. (2024). Assessing type I collagen expression and quality in cellular models of osteogenesis imperfecta. Clinical Genetics. https://doi.org/10.1111/cge.14463

Vancouver

Udupa P, Shrikondawar AN, Ranjan A, Ghosh DK. Assessing type I collagen expression and quality in cellular models of osteogenesis imperfecta. Clinical Genetics. 2024. doi:10.1111/cge.14463

BibTeX
@article{Udupa2024,
  author = {Udupa, Prajna and Shrikondawar, Akshaykumar Nanaji and Ranjan, Akash and Ghosh, Debasish Kumar},
  title = {Assessing type I collagen expression and quality in cellular models of osteogenesis imperfecta},
  journal = {Clinical Genetics},
  year = {2024},
  doi = {10.1111/cge.14463}
}
Kostenlos starten →